TELA's logo.
Ticker Symbol: TELA

TELA Bio Inc

$12.71 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001561921

Company Profile

TELA Bio Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is committed to providing patients with advanced, economically effective biologic material repair solutions to patients to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
CEO: N/A
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $7.32
Change: -$0.19 ( -2.53%)
Days Range: $7.23 - $7.62
Beta: 1.28
52wk. High: $13.18
52wk. Low: $5.68
Ytd. Change -37.23%
50 Day Moving Average: $7.70
200 Day Moving Average: $9.39
Shares Outstanding: 24487451

Valuation

Market Cap: 17.9B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A